NEW YORK, Sept. 6, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism

http://www.reportlinker.com/p0610891/Clinical-Trial-Recruitment-in-Cardiovascular-Diseases---Average-Patient-Recruitment-per-Trial-was-the-Highest-in-Venous-Thromboembolism.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism

Summary

GBI Research, the leading business intelligence provider, has released its latest research, "Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism". The report provides a robust idea about patient recruitment status by geography, sponsor companies and year for all the major CVD indications. Furthermore, the report provides prevalence forecast data to 2017 for all the major CVD indications. The major indications covered in the report are hypertension, atrial fibrillation, dyslipidemia and venous thromboembolism. The report was built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research's team of industry experts.

There has been an increase in the number of clinical trials conducted for cardiovascular diseases (CVD) due to the high prevalence of CVD. According to the American Heart Association's (AHA) 2006 data, around 81.1 million people in the US suffer from CVD and one in every 2.9 deaths in the US is due to CVD. According to the European Heart Network's 2008 data, CVD caused 4.3 million deaths (48%) in Europe. The high prevalence and mortality rate associated with CVD has led to an increase in research and development (R&D) activity by pharmaceutical companies.

Clinical trials are one of the most critical parts of the drug development process. The various aspects involved in clinical trials, such as the implementation of technology, efficient supply chain management, proper site selection, patient recruitment and database management among others, are crucially important. Clinical trial recruitment is a time intensive process so good strategies must be followed by pharmaceutical companies for proper patient recruitment.

Efficient patient recruitment leads to a decrease in the time and cost associated with patient recruitment. At present, the rate of new drug approvals is declining as pharmaceutical companies are under intense pressure to reduce the time required for drug development. It is equally important to cut the costs of clinical trials through proper patient recruitment. The delay in recruitment time is responsible for the increase in the timeline of clinical trial completion, the increase in costs to conduct the clinical trial and a delay in the time to market. There are many barriers to participation for the patients and for investigators who enroll the patients into the trials.

To complete the trial recruitment targets set by the sponsors or clinical research organizations (CROs), proper strategies must be planned in the initial phases of the trial. This will help to save time as well as costs in reaching the optimum patient pool for statistical analysis. If the recruitment is faster in the early stages of the trial, high and low potential sites can be identified. High-recruiting sites can then be allowed by the sponsors to exceed their targets in order to compensate for low recruiting sites.

Scope

The report analyzes the clinical trial recruitment trends of pharmaceutical companies for various cardiovascular trials. Its scope includes -

- Insight on clinical trials conducted for major indications of cardiology such as hypertension, atherosclerosis, atrial fibrillation and venous thromboembolism from 2000-2009.

- The status of patient recruitment by geography, sponsor company, year and stage of development.

- Analysis on the average number of patients recruited per trial for major indications per year.

- Analysis on the average number of patients recruited per trial for major indications by stage of development.

- The prevalence population in India, China and Brazil for all major indications from 2010-2017.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

- Identify and understand the status of clinical trials conducted for major cardiology indications from 2000-2009.

- Build understanding of patient recruitment status by geography, sponsor company, year and stage of development.

- Identify the prevalence population for the major indications till 2017.

- Identify the average number of patients recruited by stage of development and across years for all major indications.

- Identify the indication in which the maximum number of trials is conducted and maximum number of patients recruited.

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 9

2 Clinical Trial Recruitment in CVD - Introduction 12

2.1 GBI Research Report Guidance 13

3 Clinical Trial Recruitment in CVD - Overview 14

3.1 Clinical Trials Share by Therapeutic Area, 2005-2010 14

3.2 Clinical Trials by Major Pharmaceutical Companies, 2005-2010 21

3.3 Clinical Trial and Patient Recruitment for Major Indications, 2000-2009 22

4 Clinical Trials and Patient Recruitment for Hypertension 24

4.1 Introduction 24

4.2 Number of Clinical Trials for Hypertension 25

4.2.1 Number of Clinical Trials by Phase 25

4.2.2 Number of Clinical Trials for Hypertension by Major Sponsors 26

4.2.3 Number of Clinical Trials for Hypertension by Geography 27

4.2.4 Number of Clinical Trials for Hypertension by Year 28

4.3 Prevalence Population for Hypertension (2010-2017) 29

4.3.1 Brazil 29

4.3.2 India 30

4.3.3 China 31

4.4 Patient Recruitment for Hypertension 32

4.4.1 Number of Patients Recruited by Phase of Clinical Trial 32

4.4.2 Number of Patients Recruited by Major Sponsors 33

4.4.3 Number of Patients Recruited by Geography 34

4.4.4 Number of Patients Recruited per Year 35

4.5 Average Number of Patients Recruited Per Trial 36

4.5.1 Average Number of Patients Recruited per Trial by Stage of Development 36

4.5.2 Average Number of Patients Recruited per Trial per Year 37

5 Clinical Trials and Patient Recruitment for Atherosclerosis 38

5.1 Introduction 38

5.2 Number of Clinical Trials for Atherosclerosis 38

5.2.1 Number of Clinical Trials by Phase 38

5.2.2 Number of Clinical Trials by Sponsor 40

5.2.3 Number of Clinical Trials by Geography 41

5.2.4 Number of Clinical Trials by Year 42

5.3 Prevalence Population for Atherosclerosis (2010-2017) 43

5.3.1 Brazil 43

5.3.2 India 44

5.3.3 China 45

5.4 Patient Recruitment for Atherosclerosis 46

5.4.1 Number of Patients Recruited By Phase of Clinical Trial 46

5.4.2 Number of Patients Recruited by Sponsor 47

5.4.3 Number of Patients Recruited by Geography 48

5.4.4 Number of Patients Recruited per Year 49

5.5 Average Number of Patients Recruited per Trial 50

5.5.1 Average Number of Patients Recruited per Trial by Stage of Development 50

5.5.2 Average Number of Patients Recruited per Trial per Year 51

6 Clinical Trials and Patient Recruitment for Dyslipidemia 52

6.1 Introduction 52

6.2 Number of Clinical Trials for Dyslipidemia 52

6.2.1 Number of Clinical Trials by Phase 52

6.2.2 Number of Clinical Trials by Major Sponsor 54

6.2.3 Number of Clinical Trials by Geography 55

6.2.4 Number of Clinical Trials by Year 56

6.3 Prevalence Population for Dyslipidemia (2010-2017) 57

6.3.1 Brazil 57

6.3.2 India 58

6.3.3 China 59

6.4 Patient Recruitment for Dyslipidemia 60

6.4.1 Number of Patients Recruited by Phase of Clinical Trial 60

6.4.2 Number of Patients Recruited by Major Sponsors 61

6.4.3 Number of Patients Recruited by Geography 62

6.4.4 Number of Patients Recruited per Year 63

6.5 Average Number of Patients Recruited per Trial 64

6.5.1 Average Number of Patients Recruited per Trial by Stage of Development 64

6.5.2 Average Number of Patients Recruited per Trial per Year 65

7 Clinical Trials and Patient Recruitment for Atrial Fibrillation 66

7.1 Introduction 66

7.2 Number of Clinical Trials for Atrial Fibrillation 67

7.2.1 Number of Clinical Trials by Phase 67

7.2.2 Number of Clinical Trials by Major Sponsors 68

7.2.3 Number of Clinical Trials by Geography 69

7.2.4 Number of Clinical Trials by Year 70

7.3 Prevalence Population for Atrial Fibrillation (2010-2017) 71

7.3.1 Brazil 71

7.3.2 India 72

7.3.3 China 73

7.4 Patient Recruitment for Atrial Fibrillation 74

7.4.1 Number of Patients Recruited by Phase of Clinical Trial 74

7.4.2 Number of Patients Recruited by Major Sponsors 75

7.4.3 Number of Patients Recruited by Geography 76

7.4.4 Number of Patients Recruited per Year 77

7.5 Average Number of Patients Recruited Per Trial 78

7.5.1 Average Number of Patients Recruited per Trial by Stage of Development 78

7.5.2 Average Number of Patients Recruited per Trial per Year 79

8 Clinical Trials and Patient Recruitment for Venous Thromboembolism 80

8.1 Introduction 80

8.2 Number of Clinical Trials for Venous Thromboembolism 80

8.2.1 Number of Clinical Trials by Phase 80

8.2.2 Number of Clinical Trials by Sponsor 82

8.2.3 Number of Clinical Trials by Geography 83

8.2.4 Number of Clinical Trials by Year 84

8.3 Prevalence Population for Venous Thromboembolism (2010-2017) 85

8.3.1 Brazil 85

8.3.2 India 86

8.3.3 China 87

8.4 Patient Recruitment for Venous Thromboembolism 88

8.4.1 Number of Patients Recruited By Phase of Clinical Trial 88

8.4.2 Number of Patients Recruited by Major Sponsors 89

8.4.3 Number of Patients Recruited By Geography 90

8.4.4 Number of Patients Recruited Per Year 91

8.5 Average Number of Patients Recruited per Trial 92

8.5.1 Average Number of Patients Recruited per Trial by Stage of Development 92

8.5.2 Average Number of Patients Recruited per Trial per Year 93

9 Appendix 94

9.1 Market Definitions 94

9.2 Abbreviations 94

9.3 Research Methodology 95

9.3.1 Clinical Trials Overview 95

9.3.2 Number of Clinical Trials 95

9.3.3 Patient Recruitment Status 96

9.3.4 Prevalence of Disease in India, China and Brazil (2010-2017) 96

9.4 Coverage 96

9.5 Secondary Research 96

9.6 Primary Research 97

9.7 Expert Panel Validation 97

9.8 Contact Us 97

9.9 Disclaimer 97

9.10 Sources 98

1.1 List of Tables

Table 1: Clinical Trial Recruitment in CVD, Global, Ongoing Trials by Therapeutic Area, 2005-2010 14

Table 2: Clinical Trial Recruitment in CVD, Asia, Ongoing Trials by Therapeutic Area, 2005-2010 15

Table 3: Clinical Trial Recruitment in CVD, Europe, Ongoing Trials by Therapeutic Area, 2005-2010 16

Table 4: Clinical Trial Recruitment in CVD, Middle East, Ongoing Trials by Therapeutic Area, 2005-2010 17

Table 5: Clinical Trial Recruitment in CVD, South and Central America, Ongoing Trials by Therapeutic Area, 2005-2010 18

Table 6: Clinical Trial Recruitment in CVD, North America, Ongoing Trials by Therapeutic Area, 2005-2010 19

Table 7: Clinical Trial Recruitment in CVD, Rest of the World, Ongoing Trials by Therapeutic Area, 2005-2010 20

Table 8: Clinical Trial Recruitment in CVD, Global, Clinical Trials by Major Pharmaceutical Companies, 2005-2010 21

Table 9: Clinical Trial Recruitment in CVD, Global, Number of Clinical Trials for Major Indications, 2000-2009 22

Table 10: Clinical Trial Recruitment in CVD, Global, Number of Patients Recruited for Major Indications, 2000-2009 23

Table 11: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Clinical Trials by Phase, 2000-2009 25

Table 12: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Clinical Trials by Major Sponsors, 2000-2009 26

Table 13: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Clinical Trials by Geography, 2000 - 2009 27

Table 14: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Clinical Trials per Year, 2000 - 2009 28

Table 15: Clinical Trial Recruitment in CVD, Hypertension, Brazil, Prevalence Population, million, 2010 - 2017 29

Table 16: Clinical Trial Recruitment in CVD, Hypertension, India, Prevalence Population, million 2010 - 2017 30

Table 17: Clinical Trial Recruitment in CVD, Hypertension, China, Prevalence Population, million 2010 - 2017 31

Table 18: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Patients Recruited by Phase, 2000 - 2009 32

Table 19: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Patients Recruited by Major Sponsors, 2000 - 2009 33

Table 20: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Patients Recruited by Geography, 2000 - 2009 34

Table 21: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Patients Recruited per Year, 2000 - 2009 35

Table 22: Clinical Trial Recruitment in CVD, Hypertension, Average Number of Patients Recruited per Trial by Stage of Development, 2000 - 2009 36

Table 23: Clinical Trial Recruitment in CVD, Hypertension, Average Number of Patients Recruited per Trial per Year, 2000 - 2009 37

Table 24: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Clinical Trials, 2000 - 2009 39

Table 25: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Clinical Trials by Major Sponsors, 2000 - 2009 40

Table 26: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Clinical Trials by Geography, 2000 - 2009 41

Table 27: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Clinical Trials per Year, 2000 - 2009 42

Table 28: Clinical Trial Recruitment in CVD, Atherosclerosis, Brazil, Prevalence Population, million, 2010 - 2017 43

Table 29: Clinical Trial Recruitment in CVD, Atherosclerosis, India, Prevalence Population, million, 2010 - 2017 44

Table 30: Clinical Trial Recruitment in CVD, Atherosclerosis, China, Prevalence Population, million, 2010 - 2017 45

Table 31: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Patients Recruited by Phase, 2000 - 2009 46

Table 32: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Patients Recruited by Major Sponsors, 2000 - 2009 47

Table 33: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Patients Recruited by Geography, 2000 - 2009 48

Table 34: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Patients Recruited per Year, 2000 - 2009 49

Table 35: Clinical Trial Recruitment in CVD, Atherosclerosis, Average Number of Patients Recruited per Trial by Stage of Development, 2000 - 2009 50

Table 36: Clinical Trial Recruitment in CVD, Atherosclerosis, Average Number of Patients Recruited per Trial per Year, 2000 - 2009 51

Table 37: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Clinical Trials by Phase, 2000 - 2009 53

Table 38: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Clinical Trials by Major Sponsors, 2000 - 2009 54

Table 39: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Clinical Trials by Geography, 2000 - 2009 55

Table 40: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Clinical Trials per Year, 2000 - 2009 56

Table 41: Clinical Trial Recruitment in CVD, Dyslipidemia, Brazil, Prevalence Population, million, 2010 - 2017 57

Table 42: Clinical Trial Recruitment in CVD, Dyslipidemia, India, Prevalence Population, million, 2010 - 2017 58

Table 43: Clinical Trial Recruitment in CVD, Dyslipidemia, China, Prevalence Population, million, 2010 - 2017 59

Table 44: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Patients Recruited by Phase, 2000 - 2009 60

Table 45: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Patients Recruited by Major Sponsors, 2000 - 2009 61

Table 46: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Patients Recruited by Geography, 2000 - 2009 62

Table 47: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Patients Recruited per Year, 2000 - 2009 63

Table 48: Clinical Trial Recruitment in CVD, Dyslipidemia, Average Number of Patients Recruited per Trial by Stage of Development, 2000 - 2009 64

Table 49: Clinical Trial Recruitment in CVD, Dyslipidemia, Average Number of Patients Recruited per Trial per Year, 2000 - 2009 65

Table 50: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Clinical Trials by Phase, 2000 - 2009 67

Table 51: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Clinical Trials by Major Sponsors, 2000 - 2009 68

Table 52: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Clinical Trials by Geography, 2000 - 2009 69

Table 53: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Clinical Trials per Year, 2000 - 2009 70

Table 54: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Brazil, Prevalence Population, million, 2010 - 2017 71

Table 55: Clinical Trial Recruitment in CVD, Atrial Fibrillation, India, Prevalence Population, million, 2010 - 2017 72

Table 56: Clinical Trial Recruitment in CVD, Atrial Fibrillation, China, Prevalence Population, million, 2010 - 2017 73

Table 57: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Patients Recruited by Phase, 2000 - 2009 74

Table 58: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Patients Recruited by Major Sponsors, 2000 - 2009 75

Table 59: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Patients Recruited by Geography, 2000 - 2009 76

Table 60: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Patients Recruited per Year, 2000 - 2009 77

Table 61: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Average Number of Patients Recruited per Trial by Stage of Development, 2000 - 2009 78

Table 62: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Average Number of Patients Recruited per Trial per Year, 2000 - 2009 79

Table 63: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Clinical Trials by Phase, 2000 - 2009 81

Table 64: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Clinical Trials by Major Sponsors, 2000 - 2009 82

Table 65: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Clinical Trials by Geography, 2000 - 2009 83

Table 66: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Clinical Trials per Year, 2000 - 2009 84

Table 67: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Brazil, Prevalence Population, thousands, 2010 - 2017 85

Table 68: Clinical Trial Recruitment in CVD, Venous Thromboembolism, India, Prevalence Population, million, 2010 - 2017 86

Table 69: Clinical Trial Recruitment in CVD, Venous Thromboembolism, China, Prevalence Population, million, 2010 - 2017 87

Table 70: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Patients Recruited by Phase, 2000 - 2009 88

Table 71: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Patients Recruited by Major Sponsors, 2000 - 2009 89

Table 72: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Patients Recruited by Geography, 2000 - 2009 90

Table 73: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Patients Recruited per Year, 2000 - 2009 91

Table 74: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Average Number of Patients Recruited per Trial by Stage of Development, 2000 - 2009 92

Table 75: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Average Number of Patients Recruited per Trial per Year, 2000 - 2009 93

1.2 List of Figures

Figure 1: Clinical Trial Recruitment in CVD, Global, Ongoing Trials by Therapeutic Area, 2005-2010 14

Figure 2: Clinical Trial Recruitment in CVD, Asia, Ongoing Trials by Therapeutic Area, 2005-2010 15

Figure 3: Clinical Trial Recruitment in CVD, Europe, Ongoing Trials by Therapeutic Area, 2005-2010 16

Figure 4: Clinical Trial Recruitment in CVD, Middle East, Ongoing Trials by Therapeutic Area, 2005-2010 17

Figure 5: Clinical Trial Recruitment in CVD, South and Central America, Ongoing Trials by Therapeutic Area, 2005-2010 18

Figure 6: Clinical Trial Recruitment in CVD, North America, Ongoing Trials by Therapeutic Area, 2005-2010 19

Figure 7: Clinical Trial Recruitment in CVD, Rest of the World, Ongoing Trials by Therapeutic Area, 2005-2010 20

Figure 8: Clinical Trial Recruitment in CVD, Global, Clinical Trials by Major Pharmaceutical Companies, 2005-2010 21

Figure 9: Clinical Trial Recruitment in CVD, Global, Number of Clinical Trials for Major Indications, 2000-2009 22

Figure 10: Clinical Trial Recruitment in CVD, Global, Number of Patients Recruited for Major Indications, 2000-2009 23

Figure 11: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Clinical Trials by Phase, 2000 - 2009 25

Figure 12: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Clinical Trials by Major Sponsors, 2000 - 2009 26

Figure 13: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Clinical Trials by Geography, 2000 - 2009 27

Figure 14: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Clinical Trials per Year, 2000 - 2009 28

Figure 15: Clinical Trial Recruitment in CVD, Hypertension, Brazil, Prevalence Population, million, 2010 - 2017 29

Figure 16: Clinical Trial Recruitment in CVD, Hypertension, India, Prevalence Population, million 2010 - 2017 30

Figure 17: Clinical Trial Recruitment in CVD, Hypertension, China, Prevalence Population, million 2010 - 2017 31

Figure 18: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Patients Recruited by Phase, 2000 - 2009 32

Figure 19: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Patients Recruited by Major Sponsors, 2000 - 2009 33

Figure 20: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Patients Recruited by Geography, 2000 - 2009 34

Figure 21: Clinical Trial Recruitment in CVD, Hypertension, Total Number of Patients Recruited per Year, 2000 - 2009 35

Figure 22: Clinical Trial Recruitment in CVD, Hypertension, Average Number of Patients Recruited per Trial by Stage of Development, 2000 - 2009 36

Figure 23: Clinical Trial Recruitment in CVD, Hypertension, Average Number of Patients Recruited per Trial per Year, 2000 - 2009 37

Figure 24: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Clinical Trials, 2000 - 2009 38

Figure 25: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Clinical Trials by Major Sponsors, 2000 - 2009 40

Figure 26: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Clinical Trials by Geography, 2000 - 2009 41

Figure 27: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Clinical Trials per Year, 2000 - 2009 42

Figure 28: Clinical Trial Recruitment in CVD, Atherosclerosis, Brazil, Prevalence Population, million, 2010 - 2017 43

Figure 29: Clinical Trial Recruitment in CVD, Atherosclerosis, India, Prevalence Population, million, 2010 - 2017 44

Figure 30: Clinical Trial Recruitment in CVD, Atherosclerosis, China, Prevalence Population, million, 2010 - 2017 45

Figure 31: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Patients Recruited by Phase, 2000 - 2009 46

Figure 32: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Patients Recruited by Major Sponsors, 2000 - 2009 47

Figure 33: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Patients Recruited by Geography, 2000 - 2009 48

Figure 34: Clinical Trial Recruitment in CVD, Atherosclerosis, Total Number of Patients Recruited per Year, 2000 - 2009 49

Figure 35: Clinical Trial Recruitment in CVD, Atherosclerosis, Average Number of Patients Recruited per Trial by Stage of Development, 2000 - 2009 50

Figure 36: Clinical Trial Recruitment in CVD, Atherosclerosis, Average Number of Patients Recruited per Trial per Year, 2000 - 2009 51

Figure 37: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Clinical Trials by Phase, 2000 - 2009 52

Figure 38: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Clinical Trials by Major Sponsors, 2000 - 2009 54

Figure 39: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Clinical Trials by Geography, 2000 - 2009 55

Figure 40: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Clinical Trials per Year, 2000 - 2009 56

Figure 41: Clinical Trial Recruitment in CVD, Dyslipidemia, Brazil, Prevalence Population, million, 2010 - 2017 57

Figure 42: Clinical Trial Recruitment in CVD, Dyslipidemia, India, Prevalence Population, million, 2010 - 2017 58

Figure 43: Clinical Trial Recruitment in CVD, Dyslipidemia, China, Prevalence Population, million, 2010 - 2017 59

Figure 44: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Patients Recruited by Phase, 2000 - 2009 60

Figure 45: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Patients Recruited by Major Sponsors, 2000 - 2009 61

Figure 46: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Patients Recruited by Geography, 2000 - 2009 62

Figure 47: Clinical Trial Recruitment in CVD, Dyslipidemia, Total Number of Patients Recruited per Year, 2000 - 2009 63

Figure 48: Clinical Trial Recruitment in CVD, Dyslipidemia, Average Number of Patients Recruited per Trial by Stage of Development, 2000 - 2009 64

Figure 49: Clinical Trial Recruitment in CVD, Dyslipidemia, Average Number of Patients Recruited per Trial per Year, 2000 - 2009 65

Figure 50: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Clinical Trials by Phase, 2000 - 2009 67

Figure 51: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Clinical Trials by Major Sponsors, 2000 - 2009 68

Figure 52: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Clinical Trials by Geography, 2000 - 2009 69

Figure 53: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Clinical Trials per Year, 2000 - 2009 70

Figure 54: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Brazil, Prevalence Population, million, 2010 - 2017 71

Figure 55: Clinical Trial Recruitment in CVD, Atrial Fibrillation, India, Prevalence Population, million, 2010 - 2017 72

Figure 56: Clinical Trial Recruitment in CVD, Atrial Fibrillation, China, Prevalence Population, million, 2010 - 2017 73

Figure 57: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Patients Recruited by Phase, 2000 - 2009 74

Figure 58: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Patients Recruited by Major Sponsors, 2000 - 2009 75

Figure 59: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Patients Recruited by Geography, 2000 - 2009 76

Figure 60: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Total Number of Patients Recruited per Year, 2000 - 2009 77

Figure 61: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Average Number of Patients Recruited per Trial by Stage of Development, 2000 - 2009 78

Figure 62: Clinical Trial Recruitment in CVD, Atrial Fibrillation, Average Number of Patients Recruited per Trial per Year, 2000 - 2009 79

Figure 63: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Clinical Trials by Phase, 2000 - 2009 80

Figure 64: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Clinical Trials by Major Sponsors, 2000 - 2009 82

Figure 65: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Clinical Trials by Geography, 2000 - 2009 83

Figure 66: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Clinical Trials per Year, 2000 - 2009 84

Figure 67: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Brazil, Prevalence Population, thousands, 2010 - 2017 85

Figure 68: Clinical Trial Recruitment in CVD, Venous Thromboembolism, India, Prevalence Population, million, 2010 - 2017 86

Figure 69: Clinical Trial Recruitment in CVD, Venous Thromboembolism, China, Prevalence Population, million, 2010 - 2017 87

Figure 70: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Patients Recruited by Phase, 2000 - 2009 88

Figure 71: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Patients Recruited by Major Sponsors, 2000 - 2009 89

Figure 72: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Patients Recruited by Geography, 2000 - 2009 90

Figure 73: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Total Number of Patients Recruited per Year, 2000 - 2009 91

Figure 74: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Average Number of Patients Recruited per Trial by Stage of Development, 2000 - 2009 92

Figure 75: Clinical Trial Recruitment in CVD, Venous Thromboembolism, Average Number of Patients Recruited per Trial per Year, 2000 - 2009 93

Companies Mentioned

To order this report:

Drug Discovery and Development Industry: Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism

Drug Discovery and Development Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com